Ulf Nehrbass

Latest publications

Mass Screening for SARS-CoV-2 uncovers significant transmission risk from asymptomatic carriers.

  • Clinical and Applied Virology
  • Public Health Expertise
  • Deep Digital Phenotyping Research Unit
February 09, 2021
2021 Feb. Lancet Regl Health Europe. Accepted.
By:
  • Wilmes P
  • Zimmer J
  • Schulz J
  • Glod F
  • Veiber L
  • Mombaerts L
  • Rodrigues B
  • Aalto A
  • Pastore J
  • Snoeck C
  • Ollert M
  • Fagherazzi G
  • Mossong J
  • Goncalves J
  • Skupin A
  • Nehrbass U.

Parkinson's disease-associated alterations of the gut microbiome predict disease-relevant changes in metabolic functions.

  • Integrated BioBank of Luxembourg
  • Transversal Translational Medicine
  • Deep Digital Phenotyping Research Unit
  • PHR Custom Group 2
  • Clinical and Epidemiological Investigation Center
  • Competence Center for Methodology and Statistics
  • Luxembourg Center of Neuropathology
June 09, 2020
2020 Jun. BMC Biol.18(1):62.
By:
  • Baldini F
  • Hertel J
  • Sandt E
  • Thinnes CC
  • Neuberger-Castillo L
  • Pavelka L
  • Betsou F
  • Krüger R
  • Thiele I
  • NCER-PD Consortium (23 collaborators from LIH)
  • Aguayo G
  • Ammerlann W
  • Beaumont K
  • Esteves D
  • Ferrand JY
  • Gantenbein M
  • Geffers L
  • Graas J
  • Hanff AM
  • Hansen M
  • Huiart L
  • Larue C
  • Marques G
  • Menster M
  • Minelli M
  • Mittelbronn M
  • Mommaerts K
  • Nehrbass U
  • Perquin M
  • Schmitz S
  • Trezzi J
  • Vaillant M.